The RNA analysis market is estimated to reach USD 9.9 billion by 2028 from USD 5.3 billion in 2023, at a CAGR of 13.4% during the forecast period. The growth of this market is mainly driven by a notable surge in demand for personalized medicines, and the rising pharmaceutical and biotechnology R&D expenditure. Further, factors like government funding and increasing applications of RNA sequencing in transcriptomics are likely to uplift market growth in the coming years.
The prominent players operating in the RNA analysis market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), and Eurofins Scientific (Luxembourg).
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific, Inc. (US)
Thermo Fisher Scientific, Inc. (US) is one of the leading players in the RNA analysis market in 2022. The company’s leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of organic and inorganic growth strategies. The company has adopted different growth strategies, such as deals that include agreements, and acquisitions, to maintain its leading position in the RNA analysis market. Thermo Fisher Scientific has concentrated its focus on launching new technologies. For example, In 2021, Thermo Fisher Scientific launched novel capillary chromatography columns for proteomics, clinical peptides, and biopharmaceutical research laboratories.
F. Hoffmann-La Roche Ltd. (Switzerland)
Roche is a Swiss multinational healthcare company that is a leader in the RNA analysis market. The company offers a wide range of RNA analysis products and services, such as the Transcriptome Analysis Platform and the Exon Reporter assay. Roche is well-positioned to capitalize on the growth of the RNA analysis market because it has a strong portfolio of RNA analysis products and services, and it is investing in the development of new RNA analysis technologies.
Bio-Rad Laboratories, Inc. (US)
Bio-Rad is a prominent company that offers a wide range of products and solutions for the RNA analysis market. With a strong presence in life sciences and diagnostics, Bio-Rad provides innovative technologies and tools to enable comprehensive RNA analysis and gene expression profiling. Bio-Rad's comprehensive range of products and solutions, combined with their expertise in the field, positions them as a leading player in the RNA analysis market.
RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE